Filing Details
- Accession Number:
- 0000908662-10-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-12 12:00:00
- Reporting Period:
- 2010-01-19
- Filing Date:
- 2010-02-12
- Accepted Time:
- 2010-02-12 16:50:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 904973 | Gtc Biotherapeutics Inc | GTCB | Biological Products, (No Disgnostic Substances) (2836) | 043186494 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1356201 | A Richard Scotland | C/O Gtc Biotherapeutics, Inc. 175 Crossing Boulevard Framingham MA 01702 | Senior Vp, Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-01-19 | 14,798 | $1.13 | 0 | No | 4 | S | Indirect | By 401(k) |
| Common Stock | Acquisiton | 2010-02-09 | 14,798 | $1.08 | 14,798 | No | 4 | P | Indirect | By 401(k) |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By 401(k) |
| No | 4 | P | Indirect | By 401(k) |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,587 | Direct |
Footnotes
- Due to a percentage-based reallocation of the reporting person's 401(k) portfolio, the reporting person mistakenly caused the sale of his entire holdings of the issuer's common stock held indirectly in his 401(k) account. At the time of the reallocation the reporting person believed that the reallocation would not be applied to his holdings of issuer common stock held in his 401(k) account and, therefore, that such shares would not be sold.
- This purchase was made by the reporting person once he became aware of the sale described in Footnote #1 for the purpose of acquiring the same number of shares in his 401(k) account that he had held prior to the mistaken sale of shares. The reporting person has agreed to pay to the Issuer, upon settlement of the sale, $665.92, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
- Figure reflects an increase in holdings due to a contribution to the Reporting Person's 401(k) account in December 2009.
Billionaire Hedge Funds
